Eyal Baror, CEO & President

Eyal brings over a decade of experience in R&D and in executive-level positions in several medical device companies. A graduate of the prestigious Israel Defense Force’s Talpiot program, he holds a B.Sc. in Physics (cum-laude) from the Hebrew University of Jerusalem, and a M.Sc. in Physics (summa cum laude) from the Tel-Aviv University.


Moran Ploznik, Vice President, Clinical & Regulatory Affairs

Moran has extensive experience in managing pivotal multi-center, medical device studies. Prior to joining Neuronix, she successfully led Given Imaging Ltd.’s small-intestine pivotal-FDA study. She is a graduate of the Ben Gurion University of the Negev with a B.Sc. in Bio Medical Engineering and holds an MBA from the Technion-Israel Institute of Technology.


Rami Bernsthein, Vice President, Engineering and operations

MBA from Manchester University. Over 20 years' experience in engineering, mechanical design, manufacturing, and operations.


neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.

® August 3, 2017 Neuronix | All rights reserved.
a site by razgroup